Literature DB >> 6126436

Serological response to Escherichia coli pili in pyelonephritis.

P Rene, F J Silverblatt.   

Abstract

The serological response to Escherichia coli pili was studied in 4 adult male patients with pyelonephritis and in 11 uninfected controls. Antibody to the specific pilus antigen of the infecting strain of each patient was measured with indirect immune electron microscopy. Antibody to a cross-reacting antigen of the type 1 pili of heterologous E. coli 346 was quantitated with an enzyme-linked immunosorbent assay. Few antipilus antibodies were found in the serum of control patients with either technique. All pyelonephrine patients developed an increase in specific antipilus antibodies belonging to the immunoglobulins classes G, A, and M. Antibodies to the cross-reacting type 1 pilus antigen were found in the serum of three of the four patients and were predominantly immunoglobulin G. Few or no antipilus antibodies were present in the urine of infected or control patients. These results suggest that a serological response to the pill of infecting organisms develops after pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126436      PMCID: PMC347593          DOI: 10.1128/iai.37.2.749-754.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Antibody-coated bacteria in the urine and the site of urinary-tract infection.

Authors:  V Thomas; A Shelokov; M Forland
Journal:  N Engl J Med       Date:  1974-03-14       Impact factor: 91.245

2.  Fimbriae and adhesive properties in Salmonellae.

Authors:  J P Duguid; E S Anderson; I Campbell
Journal:  J Pathol Bacteriol       Date:  1966-07

3.  Antigen-specific serotyping of Neisseria gonorrhoeae. I. Use of an enzyme-linked immunosorbent assay to quantitate pilus antigens on gonococci.

Authors:  T M Buchanan
Journal:  J Infect Dis       Date:  1978-09       Impact factor: 5.226

4.  Antipili antibody affords protection against experimental ascending pyelonephritis.

Authors:  F J Silverblatt; L S Cohen
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

5.  The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.

Authors:  J W Smith; B Kaijser
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

6.  Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells.

Authors:  C S Edén; H A Hansson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

7.  Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection.

Authors:  C S Edén; L A Hanson; U Jodal; U Lindberg; A S Akerlund
Journal:  Lancet       Date:  1976-09-04       Impact factor: 79.321

8.  Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells.

Authors:  H Leffler; C Svanborg-Edén
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Type I Escherichia coli pili: characterization of binding to monkey kidney cells.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

10.  Host-parasite interaction in the rat renal pelvis: a possible role for pili in the pathogenesis of pyelonephritis.

Authors:  F J Silverblatt
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Interaction of bacterial pili and leukocytes.

Authors:  F J Silverblatt; I Ofek
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

2.  Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media.

Authors:  D L Gally; J A Bogan; B I Eisenstein; I C Blomfield
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

3.  Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12.

Authors:  I C Blomfield; P J Calie; K J Eberhardt; M S McClain; B I Eisenstein
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

4.  Mast cell interleukin-10 drives localized tolerance in chronic bladder infection.

Authors:  Cheryl Y Chan; Ashley L St John; Soman N Abraham
Journal:  Immunity       Date:  2013-02-15       Impact factor: 31.745

5.  Type 1 pili (F1) of porcine enterotoxigenic Escherichia coli: vaccine trial and tests for production in the small intestine during disease.

Authors:  S C To; H W Moon; P L Runnels
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

6.  Serological response to the P fimbriae of uropathogenic Escherichia coli in pyelonephritis.

Authors:  J M de Ree; J F van den Bosch
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

Review 7.  Why Serological Responses during Cystitis are Limited.

Authors:  Hae Woong Choi; Soman N Abraham
Journal:  Pathogens       Date:  2016-02-14

8.  Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli.

Authors:  Víctor M Luna-Pineda; Juan Pablo Reyes-Grajeda; Ariadnna Cruz-Córdova; Zeus Saldaña-Ahuactzi; Sara A Ochoa; Carmen Maldonado-Bernal; Vicenta Cázares-Domínguez; Leticia Moreno-Fierros; José Arellano-Galindo; Rigoberto Hernández-Castro; Juan Xicohtencatl-Cortes
Journal:  Front Cell Infect Microbiol       Date:  2016-10-31       Impact factor: 5.293

9.  P-fimbriae in the presence of anti-PapA antibodies: new insight of antibodies action against pathogens.

Authors:  Narges Mortezaei; Bhupender Singh; Esther Bullitt; Bernt Eric Uhlin; Magnus Andersson
Journal:  Sci Rep       Date:  2013-12-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.